Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;269(9):5052-5060.
doi: 10.1007/s00415-022-11161-4. Epub 2022 May 9.

Age-specific effects of childhood body mass index on multiple sclerosis risk

Affiliations

Age-specific effects of childhood body mass index on multiple sclerosis risk

Luke Hone et al. J Neurol. 2022 Sep.

Abstract

Objective: Higher body mass index (BMI) during early life is thought to be a causal risk factor for multiple sclerosis (MS). We used longitudinal Mendelian randomisation (MR) to determine whether there is a critical window during which BMI influences MS risk.

Methods: Summary statistics for childhood BMI (n ~ 28,000 children) and for MS susceptibility were obtained from recent large genome-wide association studies (GWAS) (n = 14,802 MS, 26,703 controls). We generated exposure instruments for BMI during four non-overlapping age epochs (< 3 months, 3 months-1.5 years, 2-5 years, and 7-8 years) and performed MR using the inverse variance weighted method with standard sensitivity analyses. Multivariable MR was used to account for effects mediated via later-life BMI.

Results: For all age epochs other than birth, genetically determined higher BMI was associated with an increased liability to MS: Birth [Odds Ratio (OR) 0.81, 95% Confidence Interval (CI) 0.50-1.31, Number of Single-Nucleotide Polymorphisms (NSNPs) = 7, p = 0.39], Infancy (OR 1.18, 95% CI 1.04-1.33, NSNPs = 18, p = 0.01), Early childhood (OR 1.31, 95% CI 1.03-1.66, NSNPs = 4, p = 0.03), Later childhood (OR 1.34, 95% CI 1.08-1.66, NSNPs = 4, p = 0.01). Multivariable MR suggested that these effects may be mediated by effects on adult BMI.

Conclusion: We provide evidence using MR that genetically determined higher BMI during early life is associated with increased MS risk. This effect may be driven by shared genetic architecture with later-life BMI.

Keywords: Body mass index; Causation; Epidemiology; Mendelian randomization; Multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant conflicts of interest or disclosures.

Figures

Fig. 1
Fig. 1
Forest plots showing the MR effect estimates during each epoch for the effect of BMI on MS susceptibility. Points represent beta estimates reflecting the predicted log odds ratio for MS risk per 1 unit increase in genetically determined standardised BMI at each time point. Error bars show 95% confidence intervals. The separate panels display the primary MR analytic method—the inverse variance weighted (IVW) method—followed by secondary sensitivity analyses

Similar articles

Cited by

References

    1. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13:25–36. doi: 10.1038/nrneurol.2016.187. - DOI - PubMed
    1. Davey Smith G, Ebrahim S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1. doi: 10.1093/ije/dyg070. - DOI - PubMed
    1. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601. - DOI - PMC - PubMed
    1. Munger KL, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013;19:1323–1329. doi: 10.1177/1352458513483889. - DOI - PMC - PubMed
    1. Aa. Høglund RA, et al. Association of body mass index in adolescence and young adulthood and long-term risk of multiple sclerosis: a population-based study. Neurology. 2021 doi: 10.1212/WNL.0000000000012957. - DOI - PubMed